Biology and therapeutic advances for pediatric osteosarcoma.
about
Early and late renal adverse effects after potentially nephrotoxic treatment for childhood cancerOsteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate TherapiesUnderstanding the Biology of Bone Sarcoma from Early Initiating Events through Late Events in Metastasis and Disease ProgressionExpression of the chemokine receptor CXCR7 in CXCR4-expressing human 143B osteosarcoma cells enhances lung metastasis of intratibial xenografts in SCID miceCommon variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.Selective cytotoxicity against human osteosarcoma cells by a novel synthetic C-1 analogue of 7-deoxypancratistatin is potentiated by curcuminMolecular biology and therapeutics in musculoskeletal oncology.Osteosarcomagenesis: modeling cancer initiation in the mouse.Identification of Novel Ezrin Inhibitors Targeting Metastatic Osteosarcoma by Screening Open Access Malaria Box.Detection and characterization of CD133+ cancer stem cells in human solid tumours.Comparison of long-term outcome between doublet and triplet neoadjuvant chemotherapy in non-metastatic osteosarcoma of the extremity.Canine tumor cross-species genomics uncovers targets linked to osteosarcoma progressionThe kinase Mirk is a potential therapeutic target in osteosarcoma.Proteomic analysis of osteogenic sarcoma: association of tumour necrosis factor with poor prognosis.LIM mineralization protein-1 inhibits the malignant phenotypes of human osteosarcoma cells.Human Sarcoma growth is sensitive to small-molecule mediated AXIN stabilization.The anti-tumor effect of shikonin on osteosarcoma by inducing RIP1 and RIP3 dependent necroptosis.Structuring osteosarcoma knowledge: an osteosarcoma-gene association database based on literature mining and manual annotationDRP5 is involved in cancer cell growth and predicts poor prognosis in human osteosarcomaIncreased Six1 expression is associated with poor prognosis in patients with osteosarcoma.Downregulation of calbindin 1, a calcium-binding protein, reduces the proliferation of osteosarcoma cells.Osteosarcoma Overview.Prevention of multidrug resistance (MDR) in osteosarcoma by NSC23925.Programmed cell death ligand 1 expression in osteosarcoma.MicroRNA-9 expression is a prognostic biomarker in patients with osteosarcoma.Oncostatin M promotes STAT3 activation, VEGF production, and invasion in osteosarcoma cell lines.Analysis of limb function after various reconstruction methods according to tumor location following resection of pediatric malignant bone tumors.Establishment and characterization of a new highly metastatic human osteosarcoma cell line derived from Saos2.Biomarkers in Osteosarcoma.Cemented distal femoral endoprostheses for musculoskeletal tumor: improved survival of modular versus custom implants.Nucleotide excision repair gene variants and association with survival in osteosarcoma patients treated with neoadjuvant chemotherapy.Osteosarcoma is characterised by reduced expression of markers of osteoclastogenesis and antigen presentation compared with normal boneHigh-throughput genotyping in osteosarcoma identifies multiple mutations in phosphoinositide-3-kinase and other oncogenesmicroRNA-194 suppresses osteosarcoma cell proliferation and metastasis in vitro and in vivo by targeting CDH2 and IGF1R.mTHPC-mediated photodynamic therapy is effective in the metastatic human 143B osteosarcoma cells.Cemented endoprosthetic reconstruction of the proximal tibia: how long do they last?Strategies for the targeted delivery of therapeutics for osteosarcoma.Phyllostachys edulis extract induces apoptosis signaling in osteosarcoma cells, associated with AMPK activationSilencing SATB1 inhibits the malignant phenotype and increases sensitivity of human osteosarcoma U2OS cells to arsenic trioxide.Genomic instability and telomere fusion of canine osteosarcoma cells.
P2860
Q24197545-F7E0522D-2163-4A87-8351-23FDA26E2EDBQ26782646-979C93F2-FE54-4EE2-92B6-5A3CEE50B13DQ26829949-F8D4506A-43A6-433C-B975-54995FB0D78FQ27307103-6C3AB212-8347-448F-8F82-CA2150271589Q27851470-911E9174-64EC-4F10-8DB8-3642BE427820Q28478523-3E7A8E3D-0707-4567-A8A7-DA688B530B7BQ30426953-3886E767-5841-423E-96A9-823E314FD2C5Q30476415-19944B51-9ABF-4A42-AB70-86AC7F158E20Q30488315-12DF5571-BC22-4020-A67A-3126EE5925A1Q33378520-491D1618-9C78-4E23-BB5F-DBE511AB5259Q33395803-589A22CE-8C0E-45F9-B7AE-CC4780A889CCQ33520381-F08D199C-C9D8-4C11-805E-F71F67DD2CB2Q33521423-3EF222FA-9F6A-4C29-AD14-AB42E464EED1Q33547651-E450D8EF-BBF9-4062-AFA6-C8CB158347EDQ33580856-51437537-8054-4EC9-B9DC-957734675860Q33633231-1FC48AB4-7D62-4B26-B1F7-06DBCAFA96E1Q33641040-826F2F82-DAAA-4C7D-A1D7-F8F606D4E5CDQ33666269-21656263-8F68-46D9-849A-2D822BB2B125Q33679678-8DEEB4A5-635F-4872-94C0-699E21E385F5Q33684857-32BA74DC-DB94-4EA4-B5A1-2E39D2B51E79Q33686136-811C0A4A-2700-489D-B85D-2AFD45262B8EQ33725511-1AEE1F26-9263-4168-B4E4-8455D0BED252Q33750171-B5C93757-B22D-4F0B-A874-553F4642793CQ33848154-931128C7-4895-452A-A087-42F0B2F76BA6Q33857405-68DBE3DD-6A75-4673-8803-C49BBA5B02E1Q33868158-95A4347A-46E4-4FA5-89E9-5403097068AAQ33898489-C2FD2F0D-9B71-4DD1-A73A-F34C8C5289C2Q33898688-510F4740-D425-461F-9A0B-A4F0144CEC0DQ33929072-65DD8914-A065-4955-8F18-BAEAAD60D19BQ33956306-8E8AD337-2A10-4340-9466-5CA861B5B341Q33985880-321F6788-074B-4240-86AD-BFA880CDDDC3Q34000267-858528D9-846C-4105-8E63-7E8BEE2DAF20Q34050186-AB165839-6766-4971-A4F4-C60DAA36942AQ34120352-DFD9A833-B1B7-44C3-9958-80341FC3A670Q34135844-342930D7-4005-4AEC-87E5-FF50DE53D6B3Q34164457-122927A2-916E-43BA-90AD-BE690407D77AQ34179495-DDEF471B-5EE1-4A8E-9A11-603752841ACDQ34273651-35348310-4CEF-4E64-9E27-CCF738592E7DQ34334216-2F3FDD92-BEE8-4CBE-8F5D-9400694CA1EBQ34391518-150C0D34-C39C-4E30-B57F-40CE7D5FF12B
P2860
Biology and therapeutic advances for pediatric osteosarcoma.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Biology and therapeutic advances for pediatric osteosarcoma.
@ast
Biology and therapeutic advances for pediatric osteosarcoma.
@en
type
label
Biology and therapeutic advances for pediatric osteosarcoma.
@ast
Biology and therapeutic advances for pediatric osteosarcoma.
@en
prefLabel
Biology and therapeutic advances for pediatric osteosarcoma.
@ast
Biology and therapeutic advances for pediatric osteosarcoma.
@en
P2093
P1433
P1476
Biology and therapeutic advances for pediatric osteosarcoma.
@en
P2093
Mark Gebhardt
Neyssa Marina
Richard Gorlick
P304
P356
10.1634/THEONCOLOGIST.9-4-422
P577
2004-01-01T00:00:00Z